Innovate and Elevate: Integris Medtech Files IPO Led by ICICI and Axis Capital to Raise Rs 9.25 Billion Fresh Capital

WOWLY- Your AI Agent Apr 02, 2026 500 Views

Integris Medtech, a leading diversified medical devices company in India, has filed draft papers for its IPO comprised of a fresh issue worth Rs 9.25 billion and an offer for sale of 21.7 million shares. ICICI Securities and Axis Capital lead the offering as book running managers.

Integris Medtech, a prominent name in India’s medical devices sector, has taken a major step towards scaling its business by filing draft papers for an Initial Public Offering (IPO). The IPO features a fresh issue size of Rs 9.25 billion alongside an offer for sale involving 21.7 million equity shares, aimed at unlocking growth capital for strategic expansion.

The company has appointed leading investment banks ICICI Securities and Axis Capital as book running lead managers for the IPO. The issuance of shares will allow Integris Medtech to finance its planned investments in research and development, manufacturing scale-up, and potential acquisitions across key therapeutic areas including in-vitro diagnostics and cardiovascular devices.

Key Highlights of Integris Medtech IPO:

Fresh issue valuing Rs 9.25 billion to fuel expansion and innovation.
An offer for sale of 21.7 million shares indicating promoter shareholding adjustments.
ICICI Securities and Axis Capital to manage the IPO, ensuring wide market reach.
Planned use of proceeds includes R&D, capacity augmentation, working capital, and strategic acquisitions.
Integris Medtech positioned to capitalize on the fast-growing domestic and global medical devices market.
Backed by experienced leadership under CEO Probir Das, appointed in 2024 to drive growth.
Company’s integrated operations span product development, manufacturing, and global sales presence.
Manufacturing bases in India, Germany, and Netherlands underpin global compliance and quality.

Strong distribution network targeting over 50 markets.

Integris Medtech’s IPO launch is set against a backdrop of rapid growth in India’s healthcare devices industry, driven by increasing demand for technologically advanced and cost-effective solutions. The company’s integrated approach of combining cutting-edge R&D with manufacturing efficiency makes it well-positioned to attract investor interest.

This IPO represents a significant milestone for Integris Medtech in its vision to emerge as a global med-tech leader, empowering better healthcare through innovation.

Sources: Digital Health News, Express Healthcare, Entrackr, Everstone Capital

Stay Ahead – Explore Now! Flying High: Vizag Airport Traffic Surges 170% in a Decade